GENEDX ($WGS) posted quarterly earnings results for Q4 2025 on Monday, February 23rd. The company reported earnings of $0.14 per share, beating estimates of $0.11 by $0.03. The company also reported revenue of $120,990,000, missing estimates of $121,610,736 by $-620,736.
Stock price change since market open this morning: -1.35%
You can see Quiver Quantitative's $WGS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GENEDX Insider Trading Activity
GENEDX insiders have traded $WGS stock on the open market 87 times in the past 6 months. Of those trades, 0 have been purchases and 87 have been sales.
Here’s a breakdown of recent trading of $WGS stock by insiders over the last 6 months:
- JOSHUA RUCH has made 0 purchases and 15 sales selling 38,000 shares for an estimated $6,093,967.
- KATHERINE STUELAND (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 26 sales selling 45,323 shares for an estimated $5,726,627.
- JASON RYAN has made 0 purchases and 7 sales selling 39,222 shares for an estimated $4,995,800.
- KEVIN FEELEY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 27 sales selling 18,190 shares for an estimated $2,279,865.
- BRYAN DECHAIRO (Chief Operating Officer) has made 0 purchases and 12 sales selling 9,374 shares for an estimated $850,555.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GENEDX Hedge Fund Activity
We have seen 140 institutional investors add shares of GENEDX stock to their portfolio, and 166 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 581,515 shares (-81.0%) from their portfolio in Q4 2025, for an estimated $75,631,840
- WESTFIELD CAPITAL MANAGEMENT CO LP added 474,167 shares (+87.1%) to their portfolio in Q4 2025, for an estimated $61,670,160
- FRANKLIN RESOURCES INC added 411,607 shares (+60.4%) to their portfolio in Q4 2025, for an estimated $53,533,606
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 410,928 shares (-33.7%) from their portfolio in Q4 2025, for an estimated $53,445,295
- PENTWATER CAPITAL MANAGEMENT LP removed 375,000 shares (-88.2%) from their portfolio in Q4 2025, for an estimated $48,772,500
- FMR LLC added 329,429 shares (+65.5%) to their portfolio in Q4 2025, for an estimated $42,845,535
- JENNISON ASSOCIATES LLC removed 296,277 shares (-49.5%) from their portfolio in Q4 2025, for an estimated $38,533,786
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GENEDX Analyst Ratings
Wall Street analysts have issued reports on $WGS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 12/22/2025
- BTIG issued a "Buy" rating on 10/29/2025
- Guggenheim issued a "Buy" rating on 10/29/2025
- Piper Sandler issued a "Overweight" rating on 09/11/2025
To track analyst ratings and price targets for GENEDX, check out Quiver Quantitative's $WGS forecast page.
GENEDX Price Targets
Multiple analysts have issued price targets for $WGS recently. We have seen 5 analysts offer price targets for $WGS in the last 6 months, with a median target of $170.0.
Here are some recent targets:
- Brandon Couillard from Wells Fargo set a target price of $155.0 on 02/09/2026
- Kyle Mikson from Canaccord Genuity set a target price of $170.0 on 12/22/2025
- Mark Massaro from BTIG set a target price of $200.0 on 12/12/2025
- Subbu Nambi from Guggenheim set a target price of $170.0 on 10/29/2025
- David Westenberg from Piper Sandler set a target price of $140.0 on 09/11/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
